Company Filing History:
Years Active: 1990-1995
Title: Innovations in Radiopharmaceuticals by Robert S. Hattner
Introduction
Robert S. Hattner is a notable inventor based in Mill Valley, CA (US). He has made significant contributions to the field of radiopharmaceuticals, particularly in the development of analogs of cytochalasin B. With a total of 4 patents to his name, Hattner's work has implications for nuclear imaging and glucose transport research.
Latest Patents
Hattner's latest patents focus on the use of analogs of cytochalasin B as radiopharmaceuticals for nuclear imaging. These analogs are designed to provide images that reveal glucose transport across cell membranes. Similar to cytochalasin B, these analogs specifically bind to glucose transport proteins, serving as markers for the amount of these proteins present on cell surfaces. The key innovation lies in the inclusion of a radionuclide in the terminal phenyl group of cytochalasin B, which does not interfere with the binding specificity of the analog. This allows for the development of analogs that can readily accept radionuclides at desired locations on their structure, either through conjugation or substitution.
Career Highlights
Hattner's career has been marked by his dedication to advancing the field of nuclear imaging. His work at the University of California has positioned him as a leading figure in the research and development of innovative radiopharmaceuticals. His contributions have not only enhanced scientific understanding but also opened new avenues for medical imaging techniques.
Collaborations
Hattner has collaborated with esteemed colleagues such as Barry L. Engelstad and Robert C. Brasch. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas in the field of radiopharmaceutical research.
Conclusion
Robert S. Hattner's work in developing analogs of cytochalasin B as radiopharmaceuticals represents a significant advancement in nuclear imaging technology. His contributions continue to impact the field and enhance our understanding of glucose transport mechanisms.